Skip to content
Share

|

eAlerts

|

Register

|

Login
  • Services
    • News Services
    • Conference Coverage & Reporting
    • Expert Interviews & Discussion
    • Featured Content Creation
    • Multimedia
  • Specialties
  • Showcase
  • Clients
  • News & Insights
  • About
  • Contact

Author: Lucy Piper

Support for amiloride as a spironolactone alternative in resistant hypertension

A close up view on the forearm of an African woman as she takes the readings from a blood pressure monitor, the reading falls just above the healthy range, suggesting hypertension.

The diuretic amiloride may be a suitable treatment alternative to spironolactone for patients with resistant hypertension, suggests a study published in JAMA.

Childhood cancer survivors might benefit from cochlear implants

Young woman with cochlear implant studying at home.For better learning results she using modern technology.

Childhood cancer survivors with severe to profound sensorineural hearing loss following chemotherapy or radiotherapy may be candidates for cochlear implants, US researchers believe.

Agnostic dMMR tumour PD-1 inhibitor approach may avoid resection

Depiction of immunotherapy targeting a malignant cell.

Patients with deficient mismatch repair (dMMR) cancers may not require surgery after 6 months of neoadjuvant treatment with the PD-1 inhibitor dostarlimab, suggests research published in The New England Journal of Medicine.

Lorundrostat shows promise for uncontrolled, treatment-resistant hypertension

Blood pressure measuring. Doctor and patient.

Lorundrostat, a selective aldosterone synthase inhibitor, shows blood pressure -lowering potential in people with uncontrolled and treatment-resistant hypertension, according to the Advance-HTN trial.

Polygenic risk score may improve prostate cancer screening

doctor with Blood tube and catheter for PSA Prostate specific antigen test in biochemistry lab

A polygenic risk score could help direct prostate cancer screening towards those at highest risk for the disease, the BARCODE1 investigators report.

CSF tau may flag hippocampal atrophy in new-onset refractory status epilepticus

Female Hippocampus Brain Anatomy - blue concept

Elevated total tau in cerebral spinal fluid may indicate initial brain injury in patients with cryptogenic new-onset refractory status epilepticus and predict subsequent hippocampal atrophy, suggest study findings.

Intensive systolic blood pressure control reduces CVD mortality risk in the over 80s

Female cardiologist measuring blood pressure of a senior patient during medical exam at doctor's office.

Antihypertensive treatment of patients over the age of 80 years to a target systolic blood pressure below 130 mmHg could significantly reduce their risk of death from cardiovascular disease by 26%, suggests an analysis of NHANES data.

Half-dose apixaban noninferior for preventing recurrent VTE in cancer patients

Anticoagulant pills in a prescription bottle

For patients with active cancer and venous thromboembolism, a reduced dose of apixaban is noninferior to the standard dose for preventing recurrent thromboembolic episodes and significantly reduces the risk of clinically relevant bleeding, report the API-CAT investigators.

‘Accelerated’ onset of aging-related disease highlighted for childhood cancer survivors

A Caucasian boy with cancer is indoors in his house. He is laying in a chair with a stuffed animal to comfort him. The boy is wearing a hat to cover his hair loss from chemotherapy.

Children who survive for at least 5 years after treatment for cancer are 2.7 times more likely to develop one of eight aging-related chronic health conditions before the age of 65 years than members of the general population, US researchers suggest.

Chemoprevention use after TNBC ‘may be reasonable’

Breast cancer.Female breast anatomy

Research indicates that women with triple-negative breast cancer might benefit from low-dose tamoxifen to reduce the risk of recurrent or new primary disease.

Next →

Building relationships through trusted content for healthcare professionals

GET STARTED
A global leader in medical content

© 2023 Springer Healthcare Limited.
Part of the Springer Nature Group.

Twitter Icon-social_rss
Social Share
Contact
eAlerts
Register
Login
Terms of Use
Privacy Policy
Cookie Policy